We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.47B
Cap. Flow %
10.47%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.63%
2 Consumer Discretionary 12.48%
3 Communication Services 12.09%
4 Technology 9.72%
5 Industrials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPCO
1201
DELISTED
Tribune Publishing Company Common Stock
TPCO
– –
-59,640
Closed -$823K
GWPH
1202
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-170,500
Closed -$14.9M
TCP
1203
DELISTED
TC Pipelines LP
TCP
– –
-13,529
Closed -$775K
ARA
1204
DELISTED
American Renal Associates Holdings, Inc
ARA
– –
-54,519
Closed -$1.58M
CXO
1205
DELISTED
CONCHO RESOURCES INC.
CXO
– –
-11,751
Closed -$1.4M
DNKN
1206
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-136,031
Closed -$5.93M
PTLA
1207
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-33,685
Closed -$795K
IBKC
1208
DELISTED
IBERIABANK Corp
IBKC
– –
-13,709
Closed -$819K
GNC
1209
DELISTED
GNC Holdings, Inc.
GNC
– –
-229,831
Closed -$5.58M
ACHN
1210
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-540,611
Closed -$4.22M
CPL
1211
DELISTED
CPFL Energia S.A.
CPL
– –
-14,298
Closed -$184K
WCG
1212
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-5,300
Closed -$569K
SRCI
1213
DELISTED
SRC Energy Inc
SRCI
– –
-12,362
Closed -$82K
AVP
1214
DELISTED
Avon Products, Inc.
AVP
– –
-34,076
Closed -$129K
CRZO
1215
DELISTED
Carrizo Oil & Gas Inc
CRZO
– –
-19,473
Closed -$698K
VSI
1216
DELISTED
Vitamin Shoppe Inc.
VSI
– –
-57,954
Closed -$1.77M
VIAB
1217
DELISTED
Viacom Inc. Class B
VIAB
– –
-137,430
Closed -$5.7M
GHDX
1218
DELISTED
Genomic Health, Inc.
GHDX
– –
-42,896
Closed -$1.11M
ISCA
1219
DELISTED
International Speedway Corp
ISCA
– –
-13,288
Closed -$444K
BID
1220
DELISTED
Sotheby's
BID
– –
-260,776
Closed -$7.14M
BKS
1221
DELISTED
Barnes & Noble
BKS
– –
-21,591
Closed -$245K
LLL
1222
DELISTED
L3 Technologies, Inc.
LLL
– –
-48,837
Closed -$7.16M
TIER
1223
DELISTED
TIER REIT, Inc.
TIER
– –
-18,270
Closed -$280K
BMS
1224
DELISTED
Bemis
BMS
– –
-110,363
Closed -$5.68M
HIFR
1225
DELISTED
InfraREIT, Inc.
HIFR
– –
-28,639
Closed -$502K
47 48
49
50 51

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.